<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>23540994</identifier>
<setSpec>1138-3593</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Velázquez-Lupiáñez, L</dc:author>
<dc:author>Martínez-Raposo Piedrafita, M C</dc:author>
<dc:author>Esteban-Jiménez, O</dc:author>
<dc:author>Cebollada-Gracia, A D</dc:author>
<dc:description xml:lang="en">The Primary Care physician must know the risk factors and to suspect the presence of a pulmonary thromboembolism (PTE) when there is a compatible clinical picture. We present two cases of a massive PTE in young healthy women in whom the taking of ethinylestradiol combined with cyproterone acetate was the only existing risk factor. We believe that the recommendations of the Spanish Medicines Agency should be followed and prescribe those contraceptives that have less than 30ug of ethinylestradiol and a second generation gestagen.</dc:description>
<dc:type>Case Reports</dc:type>
<dc:language>es</dc:language>
<dc:date>2013 Apr </dc:date>
<dc:title xml:lang="es">Tromboembolismo pulmonar en atención primaria.</dc:title>
<dc:title xml:lang="en">[Pulmonary thromboembolism in primary care].</dc:title>
<dc:publisher>Semergen</dc:publisher>
</metadata>
</record>
</pubmed-document>
